Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...

The results of the small study add to evidence that people find drugs like Ozempic and Wegovy helpful to manage cravings for ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

Novo Nordisk A/S NVO reported fourth-quarter 2024 earnings of 91 cents per American Depositary Receipt (ADR), which beat the ...

Diet, exercise, and other lifestyle changes work for some people with diabetes who aren't taking medication. Many people with type 1 diabetes—and some with type 2—will need to take insulin or other ...

Around half a million Britons are now thought to be using the medication, which can help them lose up to 20 per cent of their bodyweight in just a few months.

Residents and medical students will assist campers with diabetes management. As such, they will learn about blood sugar testing, insulin injections ... in numerous trials investigating new drugs to ...